Baillie Gifford & CO Sana Biotechnology, Inc. Transaction History
Baillie Gifford & CO
- $126 Billion
- Q1 2024
A detailed history of Baillie Gifford & CO transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 10,656,279 shares of SANA stock, worth $57.8 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
10,656,279
Previous 10,150,017
4.99%
Holding current value
$57.8 Million
Previous $41.4 Million
157.32%
% of portfolio
0.08%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding SANA
# of Institutions
156Shares Held
124MCall Options Held
297KPut Options Held
124K-
Flagship Pioneering Inc. Cambridge, MA25MShares$136 Million16.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$65.9 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$55.1 Million0.11% of portfolio
-
Black Rock Inc. New York, NY9.05MShares$49 Million0.0% of portfolio
-
State Street Corp Boston, MA6.37MShares$34.5 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $1.03B
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...